+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Pharmaceutical Drugs Global Market Report 2024 - Product Thumbnail Image

Pharmaceutical Drugs Global Market Report 2024

  • Report
  • February 2024
  • 400 Pages
  • Global
From
From
Neurology Market: A Research Overview - Product Thumbnail Image

Neurology Market: A Research Overview

  • Report
  • July 2019
  • 194 Pages
  • Global
From
From
Acute Spinal Cord Injury Global Market Report 2024 - Product Thumbnail Image

Acute Spinal Cord Injury Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
Pharmaceutical Drugs Industry: Global Competitive Landscape 2021 - Product Thumbnail Image

Pharmaceutical Drugs Industry: Global Competitive Landscape 2021

  • Report
  • October 2022
  • 307 Pages
  • Global
From
From
From
Pharmaceutical Market in Denmark 2024-2028 - Product Thumbnail Image

Pharmaceutical Market in Denmark 2024-2028

  • Report
  • February 2024
  • 139 Pages
  • Denmark
From
Company Snapshots: US Biotechnology - Product Thumbnail Image

Company Snapshots: US Biotechnology

  • Newsletter
  • November 2024
  • 35 Pages
  • United States
From
Digital Biomarkers: Global Markets - Product Thumbnail Image

Digital Biomarkers: Global Markets

  • Report
  • March 2022
  • 103 Pages
  • Global
From
From
Loading Indicator